A detailed history of Ritter Daniher Financial Advisory LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ritter Daniher Financial Advisory LLC holds 326 shares of VRTX stock, worth $163,798. This represents 0.04% of its overall portfolio holdings.

Number of Shares
326
Previous 326 -0.0%
Holding current value
$163,798
Previous $152,000 0.66%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $31,799 - $34,794
-78 Reduced 19.31%
326 $136,000
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $15,778 - $18,891
-46 Reduced 10.22%
404 $164,000
Q3 2023

Nov 09, 2023

BUY
$338.18 - $362.46 $62,225 - $66,692
184 Added 69.17%
450 $156,000
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $76,012 - $85,513
266 New
266 $76,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ritter Daniher Financial Advisory LLC Portfolio

Follow Ritter Daniher Financial Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritter Daniher Financial Advisory LLC , based on Form 13F filings with the SEC.

News

Stay updated on Ritter Daniher Financial Advisory LLC with notifications on news.